SUBSCRIBE
SUBSCRIBE

Alexion

NEWS
Pharm Country
Alexion Who? Buy These 4 Biotech Stocks Instead
February 20, 2017
 · 
1 min read
Deals
Alexion’s Bloated Blockbuster Deal Still Haunts
February 17, 2017
 · 
1 min read
Genetown
Why Red-Hot Alexion Is Only Suitable For Risk Takers Now
January 12, 2017
 · 
1 min read
Pharm Country
Why Alexion Is Overvalued
January 6, 2017
 · 
1 min read
Ex-Akebia Director Re-arrested After Insider Trading Prosecutors Call Him Unhinged
Business
Alexion Admits Senior Management Pressured Staff to Boost Soliris Sales
January 5, 2017
 · 
2 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Drug Development
After Fraud Probe, Alexion Reports Failed Soliris Trial
December 22, 2016
 · 
2 min read
Business
After CEO Ouster, Interim Alexion Boss Says “We Need To Move On”
December 13, 2016
 · 
1 min read
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations
Business
Alexion CEO and CFO Abruptly Step Down, Former AstraZeneca PLC CEO Named New Leader
December 12, 2016
 · 
2 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Deals
Canceled Appearance at Conference, Late 10Q Filing Fuel Alexion Acquisition Rumors
November 7, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
FDA
Alexion Receives Early FDA Approval for ULTOMIRIS™ (Ravulizumab-cwvz) in Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
December 21, 2018
 · 
23 min read
Drug Development
Comprehensive Positive Phase 3 Data for Alexion’s ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria Presented at American Society of Hematology (ASH) Annual Meeting and Published in Blood
December 3, 2018
 · 
16 min read
Genetown
Alexion to Present at the Evercore ISI Healthcare Conference
November 20, 2018
 · 
1 min read
Genetown
Alexion to Present at Credit Suisse’s 27th Annual Healthcare Conference
November 7, 2018
 · 
1 min read
Deals
Alexion Completes Acquisition of Syntimmune
November 2, 2018
 · 
7 min read
Drug Development
Alexion Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting
November 1, 2018
 · 
15 min read
Business
Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases
October 24, 2018
 · 
8 min read
Business
Alexion Reports Third Quarter 2018 Results
October 24, 2018
 · 
26 min read
Business
Alexion to Report Third Quarter 2018 Results on Wednesday, October 24, 2018
October 4, 2018
 · 
1 min read
Business
Alexion to Acquire Syntimmune
September 26, 2018
 · 
10 min read
Load More